Last reviewed · How we verify
NCT03525938
Transversus Abdominis Plane Block for Chronic Postsurgical Orchalgia
NA trial testing TAP block in Chronic Post-surgical Pain in 70 participants. Status unknown.
15 October 2019
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 10 May 2018 |
| Primary completion | 15 October 2019 |
| Estimated completion | 25 November 2019 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- TAP block
Conditions studied
- Chronic Post-surgical Pain — all drugs for Chronic Post-surgical Pain →
Sponsor
Assiut University
Who can join
Adults 18 to 80, male only, with Chronic Post-surgical Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
the study will evaluate the effect of transversus abdominis plane block (TAP) on chronic post-groin surgeries orchalgia (chronic testicular pain)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03525938
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of TAP block
Trials testing the same drug.
- NCT06556381 — Efficacy of Trans Abdominis Plane Block for Post Cesarean Delivery Analgesia · NA · recruiting
- NCT05820620 — Comparison of QLB Block and TAP Block in Morbid Obese Patients · NA · completed
- NCT05901090 — Comparing the Effects of M-TAPA and TAP Block on Postoperative Analgesia in TAH · NA · completed
- NCT05780333 — Effect of Different Plane Blocks on Quality of Recovery and Postoperative Pain After Laparoscopic Hysterectomy · NA · unknown
- NCT05686382 — TAP Block vs CWI for Total Abdominal Hysterectomy, a RCT · NA · unknown
Other recruiting trials for Chronic Post-surgical Pain
Currently open trials in the same condition.
- NCT06606067 — Duloxetine to Prevent Chronic Postsurgical Pain After Inguinal Hernia Repair in Patients at High Risk · Phase 3 · active not recruiting
- NCT06344169 — Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section · Phase 2, PHASE3 · recruiting
- NCT05920382 — Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain. · NA · recruiting
- NCT05304286 — Psychophysical and Neural Mechanisms Contributing to Chronic Post-Surgical Pain in Adolescents and Adults · NA · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03525938 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 8 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525938.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing